These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18157433)

  • 1. [Refractory schizophrenia].
    Elkis H; Meltzer HY
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S41-7. PubMed ID: 18157433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
    Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
    Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation strategies in clozapine-resistant schizophrenia.
    Remington G; Saha A; Chong SA; Shammi C
    CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.
    Honer WG; Procyshyn RM; Chen EY; MacEwan GW; Barr AM
    J Psychiatry Neurosci; 2009 Nov; 34(6):433-42. PubMed ID: 19949719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in schizophrenia.
    Zink M; Englisch S; Meyer-Lindenberg A
    Curr Opin Psychiatry; 2010 Mar; 23(2):103-11. PubMed ID: 20051861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.
    Qurashi I; Collins JD; Chaudhry IB; Husain N
    J Psychopharmacol; 2014 Jul; 28(7):707-8. PubMed ID: 24646811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.
    Stahl SM; Grady MM
    Curr Med Chem; 2004 Feb; 11(3):313-27. PubMed ID: 14965234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance is not futile: treatment-refractory schizophrenia - overview, evaluation and treatment.
    Faden J; Citrome L
    Expert Opin Pharmacother; 2019 Jan; 20(1):11-24. PubMed ID: 30407873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
    Tiihonen J; Wahlbeck K; Kiviniemi V
    Schizophr Res; 2009 Apr; 109(1-3):10-4. PubMed ID: 19186030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial.
    Pyle M; Norrie J; Schwannauer M; Kingdon D; Gumley A; Turkington D; Byrne R; Syrett S; MacLennan G; Dudley R; McLeod HJ; Griffiths H; Bowe S; Barnes TR; French P; Hutton P; Davies L; Morrison AP
    BMC Psychiatry; 2016 Aug; 16():280. PubMed ID: 27496180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis.
    Siskind DJ; Lee M; Ravindran A; Zhang Q; Ma E; Motamarri B; Kisely S
    Aust N Z J Psychiatry; 2018 Aug; 52(8):751-767. PubMed ID: 29732913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of prescription in patients with long-term treatment-resistant schizophrenia.
    Maiocchi L; Bernardi E
    Australas Psychiatry; 2013 Oct; 21(5):446-8. PubMed ID: 23873896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Roukas DK
    Eur Psychiatry; 2005 Aug; 20(5-6):409-15. PubMed ID: 16171655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
    J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
    Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
    Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S; Anıl Yağcıoğlu E
    Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.